Zurück zu Projekte

16003.1 PFLS-LS

SwissBody-enabled small molecule drug discovery for neurotransmitter/ion transporters and G protein-coupled receptors.

Zusammenfassung

SwissBody-enabled small molecule drug discovery for neurotransmitter/ion transporters and G protein-coupled receptors.

Weitere Texte

Abstract

Neurotransmitter/ion transporters and G protein-coupled receptors are druggable targets, but are suffering from a very high compound attrition rate. Recently, biophysical assays and structure-based drug design have enabled to overcome this hurdle but their development is time-consuming. Now, we aim at improving this process using synthetic camelid single domain antibody fragments (SwissBodies). In a novel and fast procedure we generate tailored SwissBodies to accelerate the development of novel biophysical tools and reduce compound attrition rates.

Beteiligte

Roger Dawson

Wirtschaftspartner

Roger.dawson@roche.com

Hoffmann-La Roche AG Roger Dawson Grenzacherstrasse 124 4070 Basel BS CH

Markus Seeger

Kontaktperson

m.seeger@imm.uzh.ch

Universität Zürich Markus Seeger Gloriastrasse 30/32 8006 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2014-04-30
Enddatum
2017-08-31
Bewilligte Gesamtkosten
CHF 715596.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%